Our fellow pharmacists in hospitals, clinics, and community pharmacies are overwhelmed right now. MedSavvy can help you during this COVID-19 health emergency. If you are a MedSavvy customer (your health plan or employer pays for MedSavvy), our services are free to you. Here's how we can help you!
At this time, there are no FDA approved medications or vaccines that specifically treat or prevent COVID-19. Globally, more than 100 clinical trials are underway to test possible treatments against SARS-CoV-2. MedSavvy pharmacists have evaluated the research on the following: chloroquine phosphate, hydroxychloroquine, favilavir, Kaletra tablet and remdesivir.
While it is currently unclear if there will be medication shortages due to COVID-19, MedSavvy is here to help when your employees are having a hard time getting the medication they need.
MedSavvy talks to Wisam Younis, PharmD, a clinical pharmacist from Regence BlueCross BlueShield, about engaging health plan members. Dr. Younis explains, “These programs do provide an ROI, but it’s vitally important the employees are engaged in order to receive value."
Courtney Schwagler is a Benefit Consultant with Advanced Benefits in Idaho. When seeking prescription benefits, her clients' primary concern is the rising cost of medications. According to Courtney, “They’re seeing six to seven-digit annual price tags on drugs, but they also want to make sure their members can still access these medications.” For example, she recently received a question from a member, “Do you think I can still get my DME (Durable Medical Equipment), if I go to Canada to buy my insulin, because I can't afford it anymore?”.
In this video, Dr. Sean Karbowicz discusses how medication cost and quality transparency can help solve wasteful medication spending and how MedSavvy can help. (Run time: 8 minutes)
Dr. Sean Karbowicz, speaks at the Business of Health Conference at the US Chamber of Commerce. Watch his presentation about transparency tools for employers. (Run time: 32 minutes)
“Congress, presidential candidates, and advocates are talking about price controls. But, what they really should be talking about is what the government can do to support a healthy marketplace for medications," says Dr. Karbowicz. Watch this video. (Run time: 2 minutes).